Associated Papers
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors.
Ahlborn LB et al.
Oncotarget, 2018
30220966 (PubMed )
Supplement: oncotarget-09-32570-s003.xlsx › Sheet1
Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60.
Reinhold WC et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2015
Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours.
Wong SQ et al.
Scientific Reports, 2013
24336498 (PubMed )
Supplement: srep03494-s1.pdf
Confirmation of a BRAF mutation-associated gene expression signature in melanoma.
Johansson P et al.
Pigment Cell Research, 2007
17516929 (PubMed )
Supplement: supplement_1.doc
Select a paper to view details